These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 38391952)

  • 21. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.
    Devic I; Hwang H; Edgar JS; Izutsu K; Presland R; Pan C; Goodlett DR; Wang Y; Armaly J; Tumas V; Zabetian CP; Leverenz JB; Shi M; Zhang J
    Brain; 2011 Jul; 134(Pt 7):e178. PubMed ID: 21349902
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease.
    Song W; Kothari V; Velly AM; Cressatti M; Liberman A; Gornitsky M; Schipper HM
    Mov Disord; 2018 Apr; 33(4):583-591. PubMed ID: 29488275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.
    Malek N; Swallow D; Grosset KA; Anichtchik O; Spillantini M; Grosset DG
    Acta Neurol Scand; 2014 Aug; 130(2):59-72. PubMed ID: 24702516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tear α-synuclein as a biomarker for Parkinson's disease: A systematic review and meta-analysis.
    Akowuah PK; Owusu E; Totoe D
    Optom Vis Sci; 2024 Jul; 101(7):485-492. PubMed ID: 39094023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of in vivo α-synuclein deposits in Parkinson's disease: A systematic review and meta-analysis.
    Tsukita K; Sakamaki-Tsukita H; Tanaka K; Suenaga T; Takahashi R
    Mov Disord; 2019 Oct; 34(10):1452-1463. PubMed ID: 31322768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease.
    Angius F; Mocci I; Ercoli T; Loy F; Fadda L; Palmas MF; Cannas G; Manzin A; Defazio G; Carta AR
    J Neurol; 2023 Nov; 270(11):5613-5621. PubMed ID: 37552278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
    Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.
    Stewart T; Sui YT; Gonzalez-Cuyar LF; Wong DT; Akin DM; Tumas V; Aasly J; Ashmore E; Aro P; Ginghina C; Korff A; Zabetian CP; Leverenz JB; Shi M; Zhang J
    Neurobiol Aging; 2014 Feb; 35(2):418-20. PubMed ID: 24041968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The central theme of Parkinson's disease: α-synuclein.
    Ozansoy M; Başak AN
    Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
    Zubelzu M; Morera-Herreras T; Irastorza G; Gómez-Esteban JC; Murueta-Goyena A
    Parkinsonism Relat Disord; 2022 Jun; 99():107-115. PubMed ID: 35717321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic utility of gut α-synuclein in Parkinson's disease: A systematic review and meta-analysis.
    Bu J; Liu J; Liu K; Wang Z
    Behav Brain Res; 2019 May; 364():340-347. PubMed ID: 30802532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Ma LY; Gao LY; Li X; Ma HZ; Feng T
    Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
    Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
    BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
    Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
    J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential roles of salivary biomarkers in neurodegenerative diseases.
    Jiao LL; Dong HL; Liu MM; Wu PL; Cao Y; Zhang Y; Gao FG; Zhu HY
    Neurobiol Dis; 2024 Apr; 193():106442. PubMed ID: 38382884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on new-age potential biomarkers for Parkinson's disease.
    Soni R; Mathur K; Shah J
    Ageing Res Rev; 2024 Feb; 94():102208. PubMed ID: 38296162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
    Atik A; Stewart T; Zhang J
    Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidate biomarkers for Parkinson's disease.
    Khodadadian A; Hemmati-Dinarvand M; Kalantary-Charvadeh A; Ghobadi A; Mazaheri M
    Biomed Pharmacother; 2018 Aug; 104():699-704. PubMed ID: 29803930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tears - more to them than meets the eye: why tears are a good source of biomarkers in Parkinson's disease.
    Edman MC; Janga SR; Kakan SS; Okamoto CT; Freire D; Feigenbaum D; Lew M; Hamm-Alvarez SF
    Biomark Med; 2020 Feb; 14(2):151-163. PubMed ID: 32064896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.